Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Hypertension

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/HJH.0b013e3282f0143cPMID 17984663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.

  2007cited by this paper
• Endothelium : Signaling , Oxidative Stress , and Gene Expression Series

  2006cited by this paper
• A place in our hearts for the lowly angiotensin 1-7 peptide?

  2006cited by this paper
• Pathophysiological regulation of the AT1-receptor and implications for vascular disease

  2006cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology

  2003cited by this paper
• Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling

  2003cited by this paper
• Multiple Interactions Between the Renin-Angiotensin and the Kallikrein-Kinin Systems: Role of ACE Inhibition and AT1 Receptor Blockade

  2002cited by this paper
• Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite.

  2001cited by this paper
• Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.

  2000cited by this paper
• Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

  2000cited by this paper
• Nitric oxide in the pathogenesis of vascular disease

  2000cited by this paper
• Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels

  2000cited by this paper
• Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis.

  1998cited by this paper
• Sustained Long Term Potentiation and Anxiety in Mice Lacking theMas Protooncogene*

  1998cited by this paper
• Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.

  1997cited by this paper
• [7-D-ALA]-angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus.

  1994cited by this paper

• Gender-dependent renal hemodynamic responses to angiotensin 1–7 following AT1 receptor blockade and chronic renal denervation in rats

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.1

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.4

  2025cites this paper
• Impact of genetic deletion of MrgD or Mas receptors in depressive-like behavior in mice.

  2022cites this paper
• Angiotensin (1−7) peptide replacement therapy with plasma transfusion in COVID-19

  2022cites this paper
• Altered heart cytokine profile and action potential modulation in cardiomyocytes from Mas-deficient mice.

  2022cites this paper
• The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic

  2022cites this paper
• Sex Difference in MasR Expression and Functions in the Renal System

  2022cites this paper
• Class A Orphans in GtoPdb v.2021.3

  2021cites this paper
• Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice

  2020cites this paper
• World Journal of Gastroenterology From to of via the gut-liver-brain axis in

  2020cites this paper
• Role of Bradykinin and Mas Receptor Blockade in Renal Vascular Responses to Angiotensin 1-7 in Adult Female Rats

  2020cites this paper
• The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential

  2020cites this paper
• Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

  2020cites this paper
• Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost

  2020cites this paper
• Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Secreted Monocyte miR-27a, via Mesenteric Arterial Mas Receptor-eNOS Pathway, Causes Hypertension.

  2019cites this paper
• Genetic Models

  2019cites this paper
• Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan.

  2018cites this paper
• Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease

  2018cites this paper
• Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension

  2018cites this paper
• Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy

  2017cites this paper
• The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

  2017cites this paper
• Mas receptor is involved in the estrogen‐receptor induced nitric oxide‐dependent vasorelaxation

  2017cites this paper
• Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney

  2017cites this paper
• Therapeutic time window for angiotensin‐(1–7) in acute lung injury

  2016cites this paper
• G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A

  2016cites this paper
• Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9).

  2015cites this paper
• Increased aortic intimal proliferation due to MasR deletion in vitro

  2015cites this paper
• Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats

  2015influential citation
• Animal Models with a Genetic Alteration of the ACE2/Ang-(1-7)/Mas Axis

  2015cites this paper
• Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome

  2015cites this paper
• Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

  2015cites this paper
• Multiple non-coding exons and alternative splicing in the mouse Mas protooncogene.

  2015cites this paper
• MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach

  2015cites this paper
• eview ovel players in cardioprotection : Insulin like growth factor-1 , ngiotensin-( 1 – 7 ) and angiotensin-( 1 – 9 )

  2015cites this paper
• Atypical Signaling and Functional Desensitization Response of MAS Receptor to Peptide Ligands

  2014cites this paper
• Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

  2014cites this paper
• Angiotensin-(1–7) Modulates Angiotensin II-Induced Vasoconstriction in Human Mammary Artery

  2014cites this paper
• Angiotensin-(1–7) Recruits Muscle Microvasculature and Enhances Insulin’s Metabolic Action via Mas Receptor

  2014cites this paper
• A Systematic Review to Investigate Whether Angiotensin-(1-7) Is a Promising Therapeutic Target in Human Heart Failure

  2013cites this paper
• Ang(1–7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes

  2013cites this paper
• Complete blockade of the vasorelaxant effects of angiotensin‐(1–7) and bradykinin in murine microvessels by antagonists of the receptor Mas

  2013influential citation
• Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

  2013cites this paper
• The ACE2/Ang-(1–7) Pathway in Cardiac Fibroblasts as a Potential Target for Cardiac Remodeling

  2013cites this paper
• Physiological Importance of Endothelium

  2013cites this paper
• Angiotensin-(1–7) Protects From Experimental Acute Lung Injury

  2013cites this paper
• Immunohistochemical localization of the angiotensin-(1–7) receptor Mas in the murine forebrain

  2012cites this paper
• Possible Involvement of Angiotensin-Converting Enzyme 2 and Mas Activation in Inhibitory Effects of Angiotensin II Type 1 Receptor Blockade on Vascular Remodeling

  2012cites this paper
• Altered regional blood flow distribution in Mas-deficient mice

  2012cites this paper
• Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors

  2012cites this paper
• Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.

  2012cites this paper
• ACE2/Angiotensin-(1-7)/Mas axis and cardiovascular regeneration

  2012cites this paper
• Cardiovascular oxidative stress: recent findin gs on ACE2 And MAO

  2012cites this paper
• The genetic deletion of Mas abolishes salt induced hypertension in mice.

  2012cites this paper
• ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease

  2011cites this paper
• The More Complex Renin-Angiotensin System: New Insights Into An Old System

  2011cites this paper
• Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate.

  2011cites this paper
• ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

  2011cites this paper
• Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

  2011influential citation
• Chronic treatment with angiotensin‐(1‐7) improves renal endothelial dysfunction in apolipoproteinE‐deficient mice

  2011cites this paper
• Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.

  2011cites this paper
• The Effect of the Thioether-Bridged, Stabilized Angiotensin-(1–7) Analogue Cyclic Ang-(1–7) on Cardiac Remodeling and Endothelial Function in Rats with Myocardial Infarction

  2011cites this paper
• Differential Mechanisms of Ang (1-7)-Mediated Vasodepressor Effect in Adult and Aged Candesartan-Treated Rats

  2011cites this paper
• Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors

  2011cites this paper
• Identifizierung von Liganden des G-Protein gekoppelten Rezeptors Mas und Mas-Sequenz-ähnlicher Rezeptoren

  2010cites this paper
• Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E–Deficient Mice

  2010cites this paper
• Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo

  2010cites this paper
• Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

  2010cites this paper
• The ubiquitin-proteasome pathway and endothelial (dys)function.

  2010cites this paper
• Physiology of kidney renin.

  2010cites this paper
• The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.

  2009cites this paper
• Therapeutic Perspectives of Angiotensin-(1-7) in the Treatment of Cardiovascular Disease

  2009cites this paper
• Genetically altered animal models for Mas and angiotensin‐(1–7)

  2008influential citation
• Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function

  2008cites this paper
• Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.

  2008cites this paper
• Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction.

  2008cites this paper
• The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.

  2008cites this paper